Overview
- The Mayo Clinic team published the 12-week, before-and-after study Thursday in Cell Reports Medicine.
- Researchers gave weekly vitamin D to 48 people with Crohn’s disease or ulcerative colitis who had low levels, then analyzed blood and stool with advanced sequencing tests.
- Supplementation was linked to higher IgA and lower IgG against gut microbes, with more activity in regulatory immune cells that help dial down inflammation.
- Disease activity scores and a stool marker of gut inflammation improved after treatment, though the single-arm design cannot show cause and effect.
- Authors urged patients to seek medical guidance on dosing and called for larger randomized trials to test benefit and safety.